Skip to main content

Vida Ventures Advisors, LLC

SEC CIK
0001831423
Latest filing
Nov 3, 2025

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Oct 5, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
8
0 vs. Q2 2022
Portfolio value
$111.4M
−$6.92M (−5.8%) vs. Q2 2022
Filed
Oct 5, 2022
SEC
Holdings of Vida Ventures Advisors, LLC in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
DYNDyne Therapeutics, Inc.COM2,220,034$28.2M25.3%−740,012−25.0%ReducedHistory
KNTEKinnate Biopharma Inc.COM2,207,772$26.4M23.7%−539,661−19.6%ReducedHistory
ALLOAllogene Therapeutics, Inc.COM1,798,163$19.4M17.4%00.0%UnchangedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS3,931,818$15.8M14.2%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,765,314$9.26M8.3%00.0%UnchangedHistory
PRAXPraxis Precision Medicines, Inc.COM2,939,329$6.67M6.0%00.0%UnchangedHistory
LIANYLianBioSPONSORED ADS2,282,084$4.56M4.1%00.0%UnchangedHistory
QTTBQ32 Bio Inc.COM696,289$1.12M1.0%−74,556−9.7%ReducedHistory